Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Tax Provisions (2024 - 2025)

Pyxis Oncology has reported Tax Provisions over the past 2 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Tax Provisions rose 151.62% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.4 million for FY2025, 164.7% up from the prior year.
  • Tax Provisions was $1.1 million for Q4 2025 at Pyxis Oncology, up from -$2.2 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.1 million in Q4 2025 and troughed at -$2.2 million in Q4 2024.